pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
CRO/CDMO · news · pharmadog
← back to CRO/CDMO
News · CRO/CDMO
102
stories
-88m
Adecto, Aviceda shut down
biospace
3h
GE HealthCare to acquire Sofie Biosciences for $945M
biopharma dive
1d
Swiss CDMOs and CROs ride a new wave of growth amid surge in global demand
biospace
4d
How to Choose a Biologics CDMO: 4 Criteria That Matter the Most
fiercebiotech
5d
Foghorn lays off 40% of employees as Lilly cancer collab collapses over poor data
fiercebiotech
6d
Webinar: From Facility to Delivery: Solving the Complex Science of ADC Linker-Payload Synthesis
biospace
6d
SK pharmteco unveils $200M+ investment to expand CDMO capabilities
endpoints
6d
Canadian $5M accelerated clinical trial program cuts start-up to 45 days
fiercebiotech
10d
After COVID, biomanufacturing tackles preparedness and commercialization challenges
biospace
13d
China’s surging biotech sector represents both competition and lifeline for the US
biospace
14d
Pentagon defends designating WuXi AppTec as Chinese military company
endpoints
15d
Beyond Random Integration: Transposase cell line development shortening timeline & boosting titers
biospace
19d
Webinar: Manufacturing in Turbulent Times
biospace
19d
DPHARM: How to address the clinical trial enrollment crisis?
fiercebiotech
19d
Biopharma hiring hotspots: States, disciplines where demand is highest
biospace
20d
FDA opens Operation TrialBlazer for applications, hoping to reshore early trials
biospace
21d
FDA launches pilot program to speed up early US drug research
biopharma dive
21d
FDA launches pilot program to speed up sluggish phase 1 trials
fiercebiotech
22d
Cyclic peptides open new drug frontiers, if manufacturing can keep up
biospace
22d
After a brief storm of political headwinds, mRNA is back with strong momentum
biospace
25d
Owkin, Servier ink oncology R&D deal to guide discovery and trial design
fiercebiotech
25d
Samsung Biologics inks $262M manufacturing deal with European pharma company
biospace
25d
Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'
fiercebiotech
25d
Lonza to build new US factory; Samsung Bio signs $262M contract
endpoints
26d
The supply chain fault lines of modern pharma
biospace
26d
August biopharma layoffs impact just over 500, down 90% year over year
biospace
27d
nPhase launches AI clinical data management platform to soup up sponsor trial design
fiercebiotech
28d
4 CDMOs to consider when outsourcing manufacturing
biospace
Sep 4, 26
Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets
endpoints
Sep 3, 26
The hidden scale-out problem behind CAR-T’s growth
biopharma dive
← prev
page 1 of 4
next →
